Gordon Fox • March 10, 2025
Camzyos is Safe

REMS works to find, stop, heart failure

The new drug Camzyos (mavacamten) has been nothing less than life changing for some patients who have HCM with obstruction. But like any drug, not all patients can take it, and not all those who take it benefit enough to stay with it. It can also add complication to a patient's life. Insurance coverage is often unpredictable. The FDA-mandated REMS  (Risk Evaluation and Management System) and warnings may seem daunting to some.

REMS is a good thing

The REMS program has some important benefits. The idea is to reduce the risk of heart failure, especially if it requires hospitalization.  For instance, if a patient's left ventricular ejection fraction(LVEF) drops below 50%, REMS mandates that the dosage of Camzyos be interrupted.

REMS data

REMS produces a lot of data, and that can help in assessing Camzyos. A group of scientists led by Matthew Martinez (Morristown Medical Center) and Milind Desai (Cleveland Clinic)  recently analyzed the data from nearly 6300 patients who received at least one dose of Camzyos (Martinez et al. 2025). There were 5573 patients with at least one report on their status (including the data from their echocardiogram).

Reduced obstruction

Camzyos provided significant reduction of obstruction. Initially all patients were obstructed (that is, they had gradients of at least 30mmHg after valsalva maneuvers). After 3 months on Camzyos, about 57% were no longer obstructed. After 6 months, about 70% had no obstruction.

Heart failure found early

But, how often did patients have problems indicating heart failure? LVEF at 50% or lower was recorded in 256 patients, 4.6% of the total. Symptomatic heart failure that required hospitalization occurred 71 (1.3%) times, and both occurred in 17 (0.3%) of the patients. When the analysis was restricted to patients who had been on Camzyos for at least a year, the numbers in these categories were roughly similar.

Conclusions

We can conclude several things. (1) Camzyos eliminates (or greatly reduces) obstruction in a majority, but not all, patients; (2) the risk of heart failure is relatively low; and (3) the REMS program is effective at protecting patients from severe heart failure and its consequences.

Literature cited

Martinez, M. W., D. Seto, M. Cheung, M. Coiro, N. Patel, A. Bastien, J. Lockman, S. Afsari, and M. Y. Desai. 2025. Mavacamten: Initial Insights From the Risk Evaluation and Mitigation Strategy Program.JACC: Advances4:101430. 

HCMA Blog

By Lisa Salberg October 10, 2025
The Price of Love: A Tribute to Esther
By Sabrina Cuddy August 1, 2025
On a background of pink
By Julie Russo July 31, 2025
Sixty years ago, Medicaid and Medicare were established when President Lyndon B. Johnson signed the Social Security Amendments into law. The programs were a larger part of Johnson's "War on Poverty" agenda to combat inequality. Sixty years later, Medicaid and Medicare are under attack in ways that we could never have imagined. With the passage of the One Big Beautiful Bill Act (OBBBA), $1 trillion was cut from Medicaid and Medicare―the largest health care cut in U.S. history. As a result of the budget package, more than 15 million people will lose health insurance, hundreds of rural hospitals will close, and approximately 51,000 people will die preventable deaths each year. Congress voted for this harm, and Congress can fix it. We need them to invest in Medicaid and Medicare in order to undo this damage. Click here to send a message to Congress telling them to invest in these critical programs, not cut them. OBBBA is the exact opposite of the "War on Poverty." The bill was passed with brutal cuts to health care to fund more tax handouts for the very wealthy. It took from the poor to give to the rich. The unpopularity of these cuts cannot be overstated. Eighty-three percent of the American public, including three in four Republicans, has a favorable view of Medicaid. Congress must hear from us loud and clear: reverse course, undo the harm to Medicaid and Medicare, and protect health care for more than 71 million people. Join us in sending the message to Congress to invest in these critical programs, don't cut them. 1 The Truth About the One Big Beautiful Bill Act’s Cuts to Medicaid and Medicare 2 Research Memo: Projected Mortality Impacts of the Budget Reconciliation Bill 3 Medicaid keeps getting more popular as Republicans aim to cut it by $800 billion
More Posts